Novo Nordisk urges FDA to prohibit manufacture of generic copies of Ozempic and Wegovy by compounding pharmacies

Weight loss stocks should grab big gains, Tema ETFs' CEO suggests

Welcome to Extreme Investor Network, your go-to source for the latest business news and insights. Today, we bring you a fascinating story about pharmaceutical giant Novo Nordisk’s efforts to prevent compounding pharmacies from making unapproved … Read more

Ozempic does not guarantee weight loss for all individuals, presenting potential investment opportunities in certain stocks

Ozempic doesn't make everyone thin. That opens up an opportunity for some stocks

Introducing Innovations in Obesity Treatment: A Look at the Impact on Bariatric Surgery and Sleep Apnea When it comes to addressing obesity and its related health issues, there are often multiple options available for patients. … Read more